CXI ヘルスケア テクノロジー グループ リミテッド - 損益計算書 (TTM)

CXI ヘルスケア テクノロジー グループ リミテッド
KR ˙ KOSDAQ
₩391.00 ↑14.00 (3.71%)
2026-05-11
株価
損益計算書 (TTM)

CXI ヘルスケア テクノロジー グループ リミテッド 損益計算書は、一定期間における収益と費用の変化を示します。損益計算書のデータには、売上高、売上総利益、研究開発費 (R&D) 、販売費、一般管理費 (SG&A) 、営業利益、所得税、支払利息、営業外収益、1株当たり利益 (EPS) 、発行済株式数が含まれています。

1株当たりの単位を除き、すべての数値は1,000,000倍です。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
収益 104,593 108,284 105,354 103,312 101,376 98,052 87,718 79,065 71,617 69,715 68,673 67,194 69,420 67,923 66,908 64,392 57,636 55,959 54,299 51,446
変化 (%) 3.53 -2.71 -1.94 -1.87 -3.28 -10.54 -9.86 -9.42 -2.66 -1.49 -2.15 3.31 -2.16 -1.49 -3.76 -10.49 -2.91 -2.97 -5.25
収益の% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
売上原価 82,777 84,441 82,360 77,548 73,018 65,732 56,934 50,696 43,405 42,030 40,944 41,104 39,544 39,752 40,338 39,665 40,320 39,315 38,744 37,134
変化 (%) 2.01 -2.46 -5.84 -5.84 -9.98 -13.38 -10.96 -14.38 -3.17 -2.58 0.39 -3.79 0.53 1.47 -1.67 1.65 -2.49 -1.45 -4.15
収益の% 79.14 77.98 78.17 75.06 72.03 67.04 64.91 64.12 60.61 60.29 59.62 61.17 56.96 58.53 60.29 61.60 69.96 70.26 71.35 72.18
営業総利益 21,816 23,843 22,994 25,764 28,358 32,320 30,784 28,369 28,213 27,685 27,729 26,090 29,876 28,170 26,571 24,726 17,316 16,644 15,555 14,311
変化 (%) 9.29 -3.56 12.05 10.07 13.97 -4.75 -7.85 -0.55 -1.87 0.16 -5.91 14.51 -5.71 -5.68 -6.94 -29.97 -3.88 -6.54 -7.99
収益の% 20.86 22.02 21.83 24.94 27.97 32.96 35.09 35.88 39.39 39.71 40.38 38.83 43.04 41.47 39.71 38.40 30.04 29.74 28.65 27.82
販管費 12,846 15,390 14,554 13,586 12,437 12,327 13,294 13,352 10,442 6,971 4,305 3,401 5,600 6,017 6,689 7,186 7,564 7,943 8,094 7,854
変化 (%) 19.80 -5.43 -6.65 -8.46 -0.89 7.85 0.43 -21.79 -33.24 -38.24 -20.99 64.64 7.44 11.17 7.43 5.26 5.01 1.90 -2.97
収益の% 12.28 14.21 13.81 13.15 12.27 12.57 15.16 16.89 14.58 10.00 6.27 5.06 8.07 8.86 10.00 11.16 13.12 14.20 14.91 15.27
研究開発 3,818 5,424 3,998 5,963 9,317 9,969 13,550 12,812 9,750 7,873 5,611 5,231 4,939 3,904 2,464 584 -3 -0 0 0
変化 (%) 42.08 -26.29 49.15 56.24 7.00 35.91 -5.45 -23.89 -19.26 -28.73 -6.77 -5.57 -20.97 -36.88 -76.30 -100.50 -98.73 -100.00 NaN
収益の% 3.65 5.01 3.79 5.77 9.19 10.17 15.45 16.20 13.61 11.29 8.17 7.78 7.12 5.75 3.68 0.91 -0.01 -0.00 0.00 0.00
運用コスト 100,064 105,861 101,332 97,397 95,085 88,471 84,383 77,605 64,482 57,769 51,728 50,597 50,767 50,125 49,774 47,488 47,937 47,328 46,924 45,091
変化 (%) 5.79 -4.28 -3.88 -2.37 -6.96 -4.62 -8.03 -16.91 -10.41 -10.46 -2.19 0.33 -1.26 -0.70 -4.59 0.94 -1.27 -0.85 -3.91
収益の% 95.67 97.76 96.18 94.27 93.79 90.23 96.20 98.15 90.04 82.86 75.32 75.30 73.13 73.80 74.39 73.75 83.17 84.58 86.42 87.65
営業利益 4,529 2,423 4,022 5,915 6,292 9,581 3,335 1,460 7,136 11,946 16,945 16,597 18,653 17,798 17,135 16,903 9,700 8,631 7,375 6,355
変化 (%) -46.51 65.99 47.07 6.37 52.29 -65.19 -56.23 388.87 67.41 41.85 -2.06 12.39 -4.59 -3.73 -1.35 -42.62 -11.02 -14.56 -13.83
収益の% 4.33 2.24 3.82 5.73 6.21 9.77 3.80 1.85 9.96 17.14 24.68 24.70 26.87 26.20 25.61 26.25 16.83 15.42 13.58 12.35
支払利息 -17 -32 -48 -48 -54 -38 -22 -22 -3 -4 -5 -6 -5 -5 -4 -4 -4 -5 -6 -6
変化 (%) 86.68 48.03 -0.93 13.01 -30.27 -42.40 2.66 -87.10 53.42 20.50 14.48 -16.39 -7.72 -7.19 -8.14 3.97 16.03 14.84 12.21
収益の% -0.02 -0.03 -0.05 -0.05 -0.05 -0.04 -0.02 -0.03 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01
純利益 5,098 2,762 4,302 6,182 5,981 9,532 3,198 1,294 7,528 12,117 17,446 21,013 29,349 28,773 27,730 23,611 12,741 11,276 9,899 8,651
変化 (%) -45.82 55.75 43.69 -3.24 59.36 -66.46 -59.53 481.71 60.96 43.98 20.45 39.67 -1.96 -3.62 -14.86 -46.04 -11.50 -12.21 -12.61
収益の% 4.87 2.55 4.08 5.98 5.90 9.72 3.65 1.64 10.51 17.38 25.40 31.27 42.28 42.36 41.45 36.67 22.11 20.15 18.23 16.82

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista